Key takeaways
- Fasting insulin measures the effort required to keep glucose normal; glucose measures only the result.
- Insulin resistance runs through years of compensated hyperinsulinaemia with normal glucose - the stage fasting insulin sees and HbA1c does not.
- Laboratory reference ranges extend far above the working targets, because they describe a population in which metabolic dysfunction is common.
- Read insulin and glucose as a pair: falling insulin with rising glucose is beta cell failure, not improvement.
- Raised insulin is harmful in itself - it suppresses lipolysis, drives hepatic lipogenesis, raises blood pressure and lowers SHBG.
A normal fasting glucose is routinely reported as reassuring. It often is not. Glucose is the variable the body is defending, and a defended variable stays normal right up until the defence fails — which means it is the last thing to move, not the first. Fasting insulin measures the effort being spent on that defence. It is inexpensive, widely available, and left off almost every standard panel, which makes it the largest gap in ordinary metabolic screening.
What the test actually measures
After an overnight fast the body is not idle. The liver is releasing glucose to keep blood levels stable, and insulin is the brake on that release. Fasting insulin therefore reports how much braking pressure is needed to hold glucose where it should be.
Two people can hold identical fasting glucose with completely different amounts of insulin doing the work. One is coasting; the other is pressing hard. Glucose cannot distinguish them. Insulin can. That is the entire argument for the test, and it is why the pair of numbers together is far more informative than either alone.
Why it moves first
Insulin resistance develops in a sequence, and the order explains the diagnostic gap (Weyer et al., J Clin Invest 1999):
- Muscle, liver and fat become less responsive to insulin. Nothing measurable changes yet.
- Beta cells compensate by secreting more. Fasting insulin rises. Glucose is still normal.
- Compensation continues, and grows. Insulin climbs further. Glucose is still normal.
- Beta cell capacity begins to fail. Post-meal glucose starts running high.
- Fasting glucose and HbA1c finally move out of range.
Stages two and three can run for years. Everything that happens during them — the visceral fat accumulation, the vascular changes, the lipid shift — is happening while the standard panel reads normal. Fasting insulin sees stages two and three. HbA1c sees stages four and five. That is not a small difference in sensitivity, it is a difference in what part of the disease you are looking at.
Reading the number
Laboratory reference ranges for insulin are notoriously wide, often extending to 25 mIU/mL, because they describe the distribution of a population in which metabolic dysfunction is common. A reference range is a description of who gets tested, not a statement about what is healthy — the distinction covered in optimal versus normal ranges. The working targets are considerably tighter:
- Under 5 mIU/mL — optimal
- 5-7 — good
- 7-10 — borderline; worth acting on before it progresses
- 10-15 — insulin resistance
- Above 15 — significant insulin resistance
Three practical caveats before treating any single result as truth. Insulin assays vary meaningfully between laboratories, so serial testing should stay with one lab. The fast needs to be a genuine 8-12 hours, water only — coffee with milk invalidates it. And a single acute stressor, illness or a very high-carbohydrate day immediately beforehand can shift a result enough to mislead. Repeat before making a decision on a borderline value.
Insulin and glucose together
The two values interpreted as a pair produce four distinct pictures, and they call for different responses.
| Fasting insulin | Fasting glucose | What it means |
|---|---|---|
| Low | Normal | Genuinely insulin sensitive |
| High | Normal | Compensated insulin resistance — the picture the standard panel misses |
| High | High | Compensation failing; overt dysfunction |
| Low or falling | High | Beta cell insufficiency — a different problem, and a more serious one |
The second row is the one this test exists for. An insulin of 12 with a glucose of 90 is a normal-looking panel describing a body working hard to stay that way (Dankner et al., Diabetes Care 2009). The fourth row is the important safety catch: falling insulin alongside rising glucose is not improvement, and reading insulin alone would score it as progress.
Combining the two arithmetically gives HOMA-IR, which is the standard way of expressing the relationship as a single figure (Matthews et al., Diabetologia 1985); HOMA-IR in detail covers its uses and its limits.
Why raised insulin is a problem in itself
It is tempting to treat high insulin as merely an early warning of diabetes — a predictor with no consequences of its own. It is not. Insulin is a growth and storage signal, and sustained elevation has direct effects.
It suppresses lipolysis, meaning stored fat is harder to release; this is the mechanistic reason fat loss feels disproportionately difficult in insulin-resistant people rather than a motivational failing. It promotes hepatic lipogenesis, which raises triglycerides and lowers HDL — the reason the triglyceride-to-HDL ratio works as a cheap surrogate for insulin resistance on a standard lipid panel. It increases renal sodium retention and sympathetic tone, contributing to blood pressure. And it lowers sex hormone binding globulin, which changes the free fraction of sex hormones in both men and women — the link between metabolic and hormonal presentations covered in SHBG.
So the years spent in compensated hyperinsulinaemia are not neutral waiting time. They are years of accumulating vascular and metabolic change with a normal-looking chart.
What lowers it, and how quickly
Fasting insulin is unusually responsive, which makes it a satisfying marker to work with — it moves on a timescale of weeks, where HbA1c takes months by construction because it reflects red cell lifespan.
- Reduce refined carbohydrate and added sugar. The fastest single change, because it lowers the demand side directly.
- Lose visceral fat. The most durable, because it removes the inflammatory and lipid signalling that caused the resistance — see how inflammation blocks insulin signalling.
- Resistance training. Muscle is the largest site of insulin-mediated glucose disposal, and contraction moves glucose transporters to the cell surface through a pathway that does not require insulin at all. More muscle is more capacity.
- Regular easy aerobic work, which improves mitochondrial handling of fuel.
- Sleep, and treatment of sleep apnoea. A few nights of restricted sleep are enough to worsen insulin sensitivity in healthy people.
- Reduce alcohol, which loads the liver directly.
- Medication where clinically indicated, as a physician's decision rather than a first move.
What to expect: dietary change usually shows within a few weeks. Training effects build over one to three months and continue as muscle mass increases. Visceral fat loss produces the largest and most permanent movement but takes longest. Re-testing sooner than about eight to twelve weeks after a change mostly measures noise.
The clinical pearl: a normal fasting glucose with an unmeasured insulin is not a clean metabolic result — it is an incomplete one. Adding a single inexpensive test to the panel converts a marker that reports failure into one that reports strain, and strain is the stage at which the problem is still cheap to fix.
Bottom line
Fasting insulin measures the effort required to keep glucose normal, which is why it changes years before glucose or HbA1c do. Interpret it alongside fasting glucose rather than alone, use tighter targets than the laboratory reference range, repeat borderline values before acting, and stay with one laboratory when tracking. High insulin with normal glucose is the finding that matters most and the one a standard panel cannot produce — and unlike HbA1c, it responds quickly enough to tell you within weeks whether what you changed is working.
Educational content, not medical advice. Laboratory interpretation and any treatment decision are made by a licensed physician after individual evaluation. Individual results vary.
